|
HU1400123A2
|
|
Salts of sunitinib, their polymorphs and pharmaceutical compositions comprising them
|
|
HU1400025A1
|
|
New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
|
|
HU1300564A2
|
|
Pharmaceutical composition comprising a cholesterol biosynthesis inhibitor and a cholesterol absorption inhibitor
|
|
HU1300565A2
|
|
Multilayer pharmaceutical composition comprising an angiotensin ii antagonist, a calcium-chanel blocker and a diuretic
|
|
HU1300504A2
|
|
Sorafenib salts
|
|
HU1300496A2
|
|
Stable pharmaceutical composition
|
|
HU1300393A2
|
|
Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
|
|
HU1300332A2
|
|
Lapatinib salts
|
|
HU1300033A2
|
|
Improved process for producing pharmaceutical agent prasugrel and 2-(2-fluorophenyl)-1-cyclopropylethanone intermediate
|
|
HU1200607A2
|
|
Diagnostic method
|
|
HU1100272A2
|
|
Pharmaceutical use of silicic acid
|
|
HU1100244A2
|
|
Pharmaceutical intermediates and process for their preparation
|
|
HU1100240A2
|
|
A novel coupling process for the production of a drug substance
|
|
HU1100238A2
|
|
Novel process for the preparation of pharmaceutically active ingredient and the intermediates arose during the process
|
|
HU1100239A2
|
|
A novel process for the preparation of a drug substance and intermediates formed during the process
|
|
SG177788A1
|
|
Transdermal pharmaceutical formulations
|
|
HU1000120D0
|
|
Stabilized pharmaceutical composition containing pregabalin and isomalt
|
|
HU1000044D0
|
|
New granulating process and the granulates prepared by this
|
|
HU1000006D0
|
|
Improved pharmaceutical composition
|
|
HU0900794D0
|
|
Process for producing prasurgel and its intermediate
|
